Form 4 for PBYI PUMA BIOTECHNOLOGY, INC.
Accepted 2022-03-04 00:00:00 ET · period of report 2022-03-02 · accession 0001437749-22-005301 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-03-04 | 2022-03-02 | PBYI | AUERBACH ALAN H | Pres, CEO, Dir, 10% | S - Sale | $2.26 | -1,294 | 4.39M | -0.0% | -$2,924 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-03-02 | S | D | 1,294 | $2.26 | 4,386,815 | D | — | — |